Answers are grounded in this paper and cite their sources.
Langerhans cells (LC) are members of antigen-presenting cells termed dendritic cells (DC). DC play a major part in initiating specific T-cell immunity by taking up antigens, processing and presenting them on their major histocompatibility complex class I and II molecules during their migration into regional lymph nodes, and by transducing activation signals to the effector T cells via costimulatory molecules and cytokine secretion. DC residing in non-lymphoid tissues are immature cells that capture antigens via specialized endocytic receptors or fluid-phase macropinocytosis. LC are differentiated DC in the epidermis and mucosal tissues, and several cytokines are supposed to affect LC phenotypes and function during their maturation.1,2 Our understanding of DC has been rapidly increasing since the discovery of the methods to expand DC from CD34+ haematopoietic progenitor cells or CD14+ peripheral blood monocytes in vitro, and cells phenotypically very similar to LC can also be generated from these progenitors. However, there are relatively few reports concerning epidermal LC themselves. To avoid confusion of the findings between DC in general and the ‘real’ LC, in this brief overview, we will focus on the current topics concerning human LC. For more comprehensive information, several excellent reviews are available.3–5 LC express several receptors for antigen uptake, including the Fcγ and Fcɛ receptors and the DEC205 multilectin. Ultrastructurally, LC have long been characterized by a unique cytoplasmic organelle, the Birbeck granule (BG), which is a disk with a tennis-racket appearance consisting of superimposed and zippered membranes. BG are recognized by the monoclonal antibody anti-Lag (Langerhans-associated granule), but the identity of the 40 kDa antigen detected with anti-Lag has yet to be determined. Recently, Valladeau et al. have identified a novel lectin named Langerin.6 It is constitutively associated with cytomembrane sandwiching structures (CMS) that lead to BG, and anti-Lag antibody recognizes an intracellular epitope of Langerin. In addition, because its lectin domain recognizes mannose that is common on microbes, Langerin functions as an endocytic receptor to translocate ligand from the cell surface into BG. These findings suggest a functional importance of BG as a novel pathway for antigen processing. It has been established that LC are bone marrow-derived leucocytes by bone marrow transplantation experiments. However, in the peripheral blood, direct precursors that will change into LC in the skin have not been well characterized. CD34+ precursors expressing the skin-homing receptor, cutaneous lymphocyte-associated antigen (CLA), and CD14+ monocytes are reported to differentiate into DC with LC-like phenotype after in vitro culture with granulocyte-monocyte colony-stimulating factor (GM-CSF) and tumour necrosis factor (TNF)-α, or GM-CSF, interleukin (IL)-4, and transforming growth factor (TGF)-β, respectively. Recently, three cellular fractions of DC have been identified in human peripheral blood, i.e. CD1a+/CD11c+/CD14–, CD1a–/CD11c+/CD14–, and CD1a–/CD11c–/CD14– fractions, and the first CD1a+/CD11c+ DC cells are considered to be the most likely candidate for the LC precursor in the human system.7 Morphologically, they are monocyte-like cells characterized by short cell processes, indented nucleus and high nuclear–cytoplasmic ratio, but there are no BGs. Phenotypically, they do not express the lineage markers for T cells (CD8, T-cell receptor, Thy-1/CD90), B cells (CD10, CD20), natural killer cells (CD56), monocytes (CD14), granulocytes (CD15, CD35), or erythrocytes (glycophorin A). They express major histocompatibility complex class II, CD4, CD13, CD33, CD45RO, CD32/CD64 (Fcγ receptors), and adhesion molecules CD11a, CD44, CD54 as well as CLA and L-selectin (CD62L, known to be a lymph node-homing molecule). As for cytokine receptors, they express GM-CSFR, but do not possess TNF receptor families, IL-1R type 1, G-CSFR, IL-2Rβ or IL-6Rβ. Functionally, they have the stimulatory activity for allogeneic T cells, and a potent ability to endocytose fluorescein isothiocyanate dextran. They quickly acquire the LC phenotype (E-cadherin, Lag and Langerin) within 1 day upon culture with GM-CSF, IL-4 and TGF-β, and finally mature into LC with high CD1a expression and BG at day 6. These results suggest that the differentiation pathway into LC has already started at the peripheral blood level. It is well investigated how LC emigrate from the skin. There is evidence indicating that topical exposures to skin-sensitizing agents stimulate LC to produce IL-1β, which acts on neighbouring keratinocytes to induce de novo synthesis of TNF-α, which in turn activates TNF-R2 on LC to trigger migration.8 In addition, chemokines such as secondary lymphoid tissue chemokine and macrophage inflammatory protein (MIP)-3β also attract DC from the site of antigen capture to the draining lymphoid organs by acting with their receptor CC chemokine receptor (CCR)-7. Although there are growing number of chemokines such as MIP-1α, -1β and -3α, monocyte chemotactic protein (MCP)-3 and -4, RANTES (regulated upon activation normal T cell expressed and secreted protein), stromal cell-derived factor-1, and macrophage-derived chemokine from in vitro study, it has not been well investigated which chemokines attract LC or LC precursors to the epidermis. Recent studies have proposed a few candidates for recruiting (putative) LC precursors into the epidermis.9,10 MIP-3α is a cytokine that has a chemotactic activity for CD34+ haematopoietic precursor cell-derived DCs but not for CD14+ monocyte-derived dendritic cells. The LC precursors (CD1a+CD14– DC derived from CD34+ chord blood cells) as well as epidermal LC express the receptor CCR6. Interestingly, they rapidly downregulate the CCR6 expression during in vitro maturation. MIP-3α is the most potent chemokine that attracts the LC precursors and the freshly isolated LC, whereas other DC precursors (CD14+CD1a– or CD14–CD1a– DC) are not attracted by MIP-3α. In vivo, MIP-3α is expressed by keratinocytes and venular endothelial cells in the skin, and clearly upregulated at sites of inflammation such as lesional psoriatic skin. In in vitro culture, MIP-3α is secreted by keratinocytes upon stimulation by IL-1β and TNF-α. These findings suggest the mechanism where the differential expression of chemokine receptors by different subsets of DC determines their in vivo location during their final differentiation. It is well known that ultraviolet (UV) irradiation, especially UVB, is hazardous for the skin. Besides its sunburn reactions in the acute phase, UVB has a suppressive effect on the skin immune system, resulting in exacerbation of skin cancer. LC are considered to be a main target of UVB irradiation. Previous findings have focused mainly on its immunosuppressive effects; high doses of UVB causes morphological degradation of LC in situ by apoptotic cell death, inhibits the capacity of LC to stimulate allogeneic T-cell reactions, and reduces expression of costimulatory molecules such as CD54 (ICAM-1), CD80 (B7-1) and CD86 (B7-2). However, there are several observations suggesting the stimulation of LC by UVB when lower doses of UV are applied under a physiological situation; moderate erythematogenic doses of solar-simulating UV irradiation enhances the costimulatory molecules CD80 and CD86 on residing LC in vivo.11 We also reported, using skin specimens that are UVB-irradiated ex vivo, that by analysing the migrating LC from the epidermis of the irradiated skin, a subset of LC demonstrated the enhanced upregulation of CD40, CD54, CD80, CD83 and CD86 being associated with reduced expression of CD1a.12 Their production of proinflammatory cytokines such as IL-1β, IL-6, IL-8 and TNF-α is enhanced by UVB. Moreover their capacity to secrete these cytokines is much higher in a per-cell basis than that of keratinocytes in our culture condition. The precise mechanism of the maturation of LC by UVB was complex, but activation of the transcription factor, NF-κB is considered to be largely involved in it.13 These results suggest an additional part played by LC for acute inflammatory reactions after solar irradiation in vivo. During the long history of LC since its discovery in 1868, their functional role as a potent antigen-presenting cell was rather recently discovered by the pioneering works by Steinman and colleagues.14 Then various cell surface costimulatory molecules as well as cytokines have been characterized to substantiate their unique function. At present a large number of experimental data has accumulated in the field of LC/DC biology. In the near future we will be able to regulate tumour immunology and autoimmune/allergic immune reactions by changing LC properties via manipulating their molecular and genomic expressions. We thank Prof. Dr Hachiro Tagami and Dr Setsuya Aiba (Department of Dermatology, Tohoku University School of Medicine) for helpful discussions.
No takes yet. Share an insight, caveat, or question.
Nakagawa et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: